Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 22, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 24, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001201252-26-000010
Filed / recorded
Jul 24, 2026, 12:48 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Victor J Dzau
Relationship
Director
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Jul 22, 2026
Transaction code
A
Shares / units
730
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
730
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
In connection with Dr. Dzau's appointment to the Board of Directors on July 22, 2026, he was awarded restricted stock units and stock options in accordance with the Non-Employee Director Compensation Program, as follows: (a) 380 restricted stock units and 1,190 stock options, representing his initial grant upon joining the Board, and (b) 350 restricted stock units and 1,110 stock options, which are pro-rata grants representing the remainder of the 2026-2027 Board service year. Each award becomes fully vests on the one-year anniversary of the grant date.
Not applicable as restricted stock units do not have an expiration date.